Nick Manamley
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials.
Journal: Critical care (London, England)
Published: July 24, 2024
Clinical and mycological outcomes of candidaemia and/or invasive candidiasis by Candida spp. and antifungal susceptibility: pooled analyses of two randomized trials of rezafungin versus caspofungin.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: July 05, 2024
Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials.
Journal: Critical care (London, England)
Published: May 30, 2024
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.
Journal: Hematological oncology
Published: May 24, 2024
Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: February 15, 2024
Data sharing and the evolving role of statisticians.
Journal: BMC medical research methodology
Published: July 14, 2016
Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 08, 2015
Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study.
Journal: Pediatric nephrology (Berlin, Germany)
Published: July 09, 2015
AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: June 12, 2015
Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM study.
Journal: Advances in therapy
Published: September 10, 2014
Last Updated: 09/26/2026